DonateWe are Make 2nds Count: a UK-wide patient and family focused charity dedicated to giving hope to women and men living with secondary (metastatic) breast cancer.
Research into secondary breast cancer is underfunded. We are committed to funding secondary breast cancer research which can contribute to advancing an increased quality of life for patients.
Our in-person and online Support programme helps our community with information sharing, practical advice and support, wellbeing activities and facilitating peer-to-peer friendship groups.
Education is key to everything that we do and we aim to raise awareness of secondary breast cancer through effective marketing and education programmes across the UK. We also empower our community by increasing their knowledge and understanding of research, treatments, trials and options.
Together we can Make 2nds Count!
Sponsor our Clinical Trials Nurse
We've launched our Big Give appeal to raise £5,000 in seven days — and thanks to The Big Give, it will be doubled!
That’s £10,000 to fund 80 sessions with our Clinical Trials Nurse, Mel. These sessions help people living with secondary breast cancer navigate the world of clinical trials and explore potential new treatment options.
Once we have met the £5,000 target, any donations can continue to be added to the pot for additional appointments but they won't be matched.
Please give what you are able: https://tinyurl.com/ye733862
Signs & Symptoms of Secondary Breast Cancer
Secondary (metastatic) breast cancer is a cancer that has spread beyond the breast to other parts of the body.
An estimated 61,000 men and women in the UK are living with this incurable disease, and symptoms can vary from person to person. It has a devastating impact on people affected and their families, yet many people have never heard of it. It is one of the biggest killers of women under 50 in the UK.
Secondary breast cancer can be treated but it cannot be cured. Treatments aim to control and slow down the disease to enable patients to have the best possible quality of life for as long as possible.
Living with a secondary breast cancer diagnosis is both mentally and physically gruelling and can be incredibly isolating. Our support programme helps our community by informing, sharing, fostering important relationships, and offering practical advice.
- Tea & Chat - we have 21 regional in-person monthly groups that are safe spaces to build friendships and get peer-to-peer support.
- Wellbeing sessions - our weekly online activities including Pilates, Yoga, Breathwork and Mindfulness, all designed to help mental and physical health.
- Online community - join our closed Facebook group to connect with others, share information and get support.
Join our support sessions
Clinical Trials Service
Our free information and support service is here to help secondary breast cancer patients explore clinical trials as part of their treatment pathway.
Understanding and navigating the world of clinical trials can feel overwhelming. Our Clinical Trials Nurse Mel has years of experience in secondary breast cancer and clinical trials and is here to help answer your questions and conduct a trial database search on your behalf. If you are living with metastatic breast cancer and interested in finding out more, please complete a referral form using the button below.
North Downs 50 Ultra Challenge
Join us in the North Downs with a fabulous challenge setting out from a Guildford basecamp. Take in some of the best of the Surrey hills, the
North Downs Way, and the surrounding countryside.
Patient Trustee Lesley Stephen is awarded MBE
We are delighted that our Patient Trustee, Lesley Stephen, has been awarded an MBE in the King's Birthday Honours list for services to secondary (metastatic) breast cancer. Lesley, from Edinburgh, was diagnosed with 'de novo' secondary breast cancer in March 2014.
Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) Charity Coalition Statement
The Charities Medicines Access Coalition (CMAC), a coalition of 26 health charities including Make 2nds Count representing millions of patients across the UK, is calling for the Government and the pharmaceutical industry to be more transparent and share clear evidence that patient impact is at the heart of the ongoing pricing and access discussions and negotiations. The review of the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG), expected in Autumn 2025, has been brought forward and is due to conclude at the end of June 2025.